Allergic Conjunctivitis during Outdoor Exercise: Current Management Strategies and Implications for Athletic Performance
DOI:
https://doi.org/10.12775/QS.2026.65.73874Keywords
allergic conjunctivitis, aeroallergens, air pollution, soft steroids, immunotherapyAbstract
Background: Allergic conjunctivitis (AC) in athletes is an inflammatory disorder of the ocular surface and a primary driver of exercise-related performance impairment, orchestrated by underlying IgE-mediated hypersensitivity and synergistic environmental triggers.
Aim of the study: This narrative review aims to synthesize current literature on the immunopathology and modern therapeutic landscape of allergic conjunctivitis (AC), with a specific focus on optimizing clinical management for athletes and physically active individuals.
Materials and Methods: A comprehensive assessment of peer-reviewed literature published between 2020 and 2026 was conducted using databases such as PubMed and Cochrane Library, prioritizing clinical trials, systematic reviews, and updated management guidelines.
Results: Modern management has transitioned toward topical dual-action agents as first-line therapy, supplemented by preservative-free formulations to protect ocular surface homeostasis.
Conclusions: Effective management of AC is essential for maintaining the quality of life and athletic performance of physically active individuals. Integrating evidence-based pharmacological strategies with non-pharmacological interventions, while avoiding the sedative effects of systemic treatments, is critical for optimizing ocular health in sporting contexts.
References
Leonardi A, Quintieri L, Presa IJ, LLoves JM, Montero J, Benítez-Del-Castillo JM, Lestón FJS, González-Mancebo E, Asero R, Groblewska A, Kuna P. Allergic Conjunctivitis Management: Update on Ophthalmic Solutions. Curr Allergy Asthma Rep. 2024 Jul;24(7):347-360. https://doi.org/10.1007/s11882-024-01150-0
Tariq F. Allergic Conjunctivitis: Review of Current Types, Treatments, and Trends. Life (Basel). 2024 May 21;14(6):650. https://doi.org/10.3390/life14060650
Tao Z, Liu W, Chen Q, Zhang L, She K, Zhao G, Liang L, Chen X, Yang Y, Song Q, Lu F. Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis. Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):30. https://doi.org/10.1167/iovs.64.10.30
Ravindra K, Goyal A, Mor S. Pollen allergy: Developing multi-sectorial strategies for its prevention and control in lower and middle-income countries. Int J Hyg Environ Health. 2022 May;242:113951. https://doi.org/10.1016/j.ijheh.2022.113951
Gianni M. Evolution of Immunotherapy Against Pollen Allergy. Curr Protein Pept Sci. 2023;24(6):488-502. https://doi.org/10.2174/1389203724666230303091754
Akasaki Y, Inomata T, Sung J, Nakamura M, Kitazawa K, Shih KC, Adachi T, Okumura Y, Fujio K, Nagino K, Midorikawa-Inomata A, Kuwahara M, Hirosawa K, Huang T, Morooka Y, Shokirova H, Eguchi A, Murakami A. Prevalence of Comorbidity between Dry Eye and Allergic Conjunctivitis: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Jun 23;11(13):3643. https://doi.org/10.3390/jcm11133643
Creticos PS, Gunaydin FE, Nolte H, Damask C, Durham SR. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma. J Allergy Clin Immunol Pract. 2024 Jun;12(6):1415-1427. https://doi.org/10.1016/j.jaip.2024.04.034
Treatment of allergic rhinitis and allergic conjunctivitis. Med Lett Drugs Ther. 2025 Mar 31;67(1725):49-56. https://doi.org/10.58347/tml.2025.1725a
Chigbu DI, Karbach NJ, Abu SL, Hehar NK. Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles. Life (Basel). 2024 Mar 7;14(3):350. https://doi.org/10.3390/life14030350
Tanaka H, Tatsukawa Y, Yoshitomi K, Tabuchi H, Fukushima A. Effects of Antihistamine-Releasing Contact Lenses on Severe Allergic Conjunctivitis. Ocul Immunol Inflamm. 2023 Oct;31(8):1674-1676. https://doi.org/10.1080/09273948.2022.210300
Martinez-Perez C, Oliveira AP. Air Pollution, Pollen, and Indoor Exposures in Allergic Conjunctivitis: A Systematic Review. Life. 2026; 16(2):271. https://doi.org/10.3390/life16020271
Kalangara JP, Vanijcharoenkarn K, Chisolm S, Kuruvilla ME. Neuropathic pain and itch: mechanisms in allergic conjunctivitis. Curr Opin Allergy Clin Immunol. 2022 Oct 1;22(5):298-303 https://doi.org/10.1097/ACI.0000000000000843
Ben-Eli H, Solomon A. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends. Curr Opin Allergy Clin Immunol. 2018 Oct;18(5):411-416 https://doi.org/10.1097/ACI.0000000000000473
Fu X, Xu P, Lu D. Comparative assessment of alcaftadine and olopatadine for allergic conjunctivitis: a meta-analysis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2024;41(6):560-565. https://doi.org//10.5114/ada.2024.144166
Fernandez A, Asbell P, Roy N. Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis. Ocul Surf. 2022 Oct;26:191-196. https://doi.org/10.1016/j.jtos.2022.08.004
Dupuis, P., Prokopich, C., Hynes, A. et al. A contemporary look at allergic conjunctivitis.Allergy Asthma Clin Immunol 16, 5 (2020). https://doi.org/10.1186/s13223-020-0403-9
Miyazaki D, Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Satake Y, Shoji J, Namba K, Fukagawa K, Fukushima A, Fujishima H; Japanese Society of Ocular Allergology; Japanese Society of Allergology. Japanese guidelines for allergic conjunctival diseases 2020. Allergol Int. 2020 Jul;69(3):346-355. https://doi.org/10.1016/j.alit.2020.03.005
Chan VF, Yong AC, Azuara-Blanco A, Gordon I, Safi S, Lingham G, Evans J, Keel S. A Systematic Review of Clinical Practice Guidelines for Infectious and Non-infectious Conjunctivitis. Ophthalmic Epidemiol. 2022 Oct;29(5):473-482. https://doi.org/10.1080/09286586.2021.1971262
Dornquast C, Rotter G, Schollbach L, Binting S, Scherr J, Pfab F, Brinkhaus B. Allergic diseases in German competitive athletes: results of a cross-sectional study. J Sports Med Phys Fitness. 2023 Apr;63(4):588-595. https://doi.org/10.23736/S0022-4707.22.13825-9
Wan Abdul Halim WH, Jamaludin MI, Cheng TC. Corneal biomechanics in patients with allergic conjunctivitis. Indian J Ophthalmol. 2024 Nov 1;72(Suppl 5):S728-S733. https://doi.org/10.4103/IJO.IJO_654_24
Ogura A, Sugimoto Y. A mouse model of allergic conjunctivitis permitting tear eosinophil quantification. J Pharmacol Toxicol Methods. 2022 Nov-Dec;118:107225. https://doi.org/10.1016/j.vascn.2022.107225
Abu SL, Hehar NK, Chigbu DI. Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis. Curr Opin Allergy Clin Immunol. 2024 Oct 1;24(5):380-389. https://doi.org/10.1097/ACI.0000000000001010
Kausar A, Akhtar N, Akbar N. Epidemiological Aspects Of Allergic Conjunctivitis. J Ayub Med Coll Abbottabad. 2022 Jan-Mar;34(1):135-140 https://doi.org/10.55519/JAMC-01-9432
Bao J, Wen Y, Tian L, Jie Y. Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms. Clin Rev Allergy Immunol. 2025 Aug 29;68(1):85. https://doi.org/10.1007/s12016-025-09098-3
Chigbu DI, Karbach NJ, Abu SL, Hehar NK. Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles. Life (Basel). 2024 Mar 7;14(3):350. https://doi.org/10.3390/life14030350
Iordache A, Boruga M, Mușat O, Jipa DA, Tătaru CP, Mușat GC. Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review. Rom J Ophthalmol. 2022 Jan-Mar;66(1):8-12. https://doi.org/10.22336/rjo.2022.3
Sözener ZÇ, Öztürk BÖ, Aydın Ö, Demirel YS, Pınar NM, Bavbek S, Sin BA, Mungan D. Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors - lesser allergy symptoms in 2020. Asia Pac Allergy. 2021 Apr 21;11(2):e16. https://doi.org/10.5415/apallergy.2021.11.e16
Ogura A, Sugimoto Y. A mouse model of allergic conjunctivitis permitting tear eosinophil quantification. J Pharmacol Toxicol Methods. 2022 Nov-Dec;118:107225. https://doi.org/10.1016/j.vascn.2022.107225
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Katarzyna Zegadło, Kornelia Nieradka, Patryk Jakubiak, Krzysztof Brzezicki, Katarzyna Jolanta Kuc, Maciej Dobrucki, Dominika Krakowiak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 25
Number of citations: 0
